Annie Sundelson, MSc
Ms. Sundelson is a doctoral student in the Department of Environmental Health and Engineering (Health Security Track) at Johns Hopkins Bloomberg School of Public Health. Her research interests pertain to health security in the context of the former Soviet Union. She is particularly interested in Russian state-sponsored disinformation about biological weapons.
Prior to starting her doctoral studies, Ms. Sundelson was a research assistant at the Columbia Mailman School of Public Health, where she worked on an NIH-funded study of HIV-related risk behavior among men who have sex with men in the US. She has professional working proficiency in Russian and spent a year abroad in Almaty, Kazakhstan, where she interned at a local cardiology clinic.
Ms. Sundelson received an MSc in reproductive and sexual health research from the London School of Hygiene and Tropical Medicine (LSHTM) and a BA in Russian language and literature from the University of California, Los Angeles (UCLA).
Ms. Walker is a doctoral student in Department of Environmental Health and Engineering (Health Security Track) at Johns Hopkins Bloomberg School of Public Health. Prior to beginning her doctoral studies, Caitlin worked as a Senior Health Analyst for the UK Health Security Agency. Previously, she has worked with Public Health England and interned with the United Nations Joint Programme on HIV/AIDS (UNAIDS).
Ms. Walker holds a BA in biological natural sciences from the University of Cambridge.
Matthew E. Walsh
Mr. Walsh is a doctoral student in the Department of Environmental Health and Engineering (Health Security Track) at Johns Hopkins Bloomberg School of Public Health and a member of the 2018 cohort of the Emerging Leaders in Biosecurity Initiative (ELBI).
Previously, he was Associate Staff in the Biological and Chemical Technologies group at MIT Lincoln Laboratory (MIT LL), a Department of Defense Research and Development Laboratory. He established a technical program at MIT LL to develop and apply machine learning methods to engineering biology with a focus on rapid medical countermeasures and antibody-based therapeutics. Mr. Walsh also has supported work in biosensor development, threat attribution, warfighter health, and biological data assurance. Prior to MIT LL, he worked at MassBiologics of the University of Massachusetts Medical School, developing assays for the characterization of therapeutic monoclonal antibody production.
Mr. Walsh received a BA in chemistry from Skidmore College.